黑料官网

header-logo
GettyImages-609179959-hero
headshot

Julie Jorns, MD

Professor

view physician profile

Locations

  • Pathology - Froedtert Hospital

Specialties

  • Pathology - Anatomic

Languages

  • English

Education

  • MD - Doctor of Medicine

Biography

Dr. Jorns serves as the Director of Breast Pathology and the Breast/Gynecologic Pathology Fellowship with the 黑料官网 Department of Pathology and Laboratory Medicine and Froedtert Hospital. Dr. Jorns’ responsibilities include breast and surgical pathology as well as teaching of medical students, residents, and fellows.

Research Interests

Breast pathology

Frozen section pathology

Quality assurance

Publications

  • (Koshy R, Jain PV, Jorns JM.) Histopathology. 2026 Feb 23 PMID: 41731999 SCOPUS ID: 2-s2.0-105031127582 02/24/2026

  • (Katsma A, Jorns JM, Gardner P, Wolden M, Leuther K.) BMJ Open Qual. 2026 Feb 06;15(1) PMID: 41651556 PMCID: PMC12887483 SCOPUS ID: 2-s2.0-105029607355 02/07/2026

  • (Jorns JM, Smith RS, Strenk D, Stauble G, Khelifa S, Seltzer R, Manuel J, Rosenbaum MW, Almas J, Li Z.) J Clin Pathol. 2026 Jan 19;79(2):132-137 PMID: 40850743 PMCID: PMC12911634 SCOPUS ID: 2-s2.0-105014387841 08/25/2025

  • (Sivasubramaniam P, Parsons L, Polley M, Scheel K, Jorns JM.) Am J Clin Pathol. 2026 Jan 05;165(2) PMID: 41643207 SCOPUS ID: 2-s2.0-105029610324 02/05/2026

  • (Niu T, Ampo E, Jorns JM, Patton M, Lu T, Ye DH, Yen TWF, Yu B.) J Biomed Opt. 2026 Jan;31(1):016501 PMID: 41451238 PMCID: PMC12733377 SCOPUS ID: 2-s2.0-105025842305 12/26/2025

  • (Molina M, Moreno G, Jorns JM.) Int J Surg Pathol. 2025 Dec;33(8):1774-1777 PMID: 40448332 SCOPUS ID: 2-s2.0-105007138055 05/31/2025

  • (Pourfarrokh N, Ateek GN, Jorns JM, Stewart BD, Asirvatham JR.) Arch Pathol Lab Med. 2025 Aug 01;150(2):160-166 PMID: 40745930 SCOPUS ID: 2-s2.0-105028697346 08/01/2025

  • (Afshin P, Helminiak D, Lu T, Yen T, Jorns JM, Patton M, Yu B, Ye DH.) Annu Int Conf IEEE Eng Med Biol Soc. 2025 Jul;2025:1-6 PMID: 41335967 SCOPUS ID: 2-s2.0-105023728989 12/03/2025

  • (Johnson AL, Tau S, Sloop AM, Dai T, Roberts AM, Muskus P, Warren A, Kleist SA, Hampsch RA, Jorns JM, Zhang R, Jarvis LA, Miller TW.) Cancers (Basel). 2025 Jun 09;17(12) PMID: 40563571 PMCID: PMC12190792 06/26/2025

  • (Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K.) Clin Breast Cancer. 2025 Apr;25(3):251-260 PMID: 39824712 SCOPUS ID: 2-s2.0-85215561512 01/18/2025

  • (Cobb AN, Czaja R, Jorns J, Cortina CS.) Curr Breast Cancer Rep. 2024 Jun;16(2):150-160 PMID: 40574868 PMCID: PMC12199283 06/27/2025

  • (Ghahfarokhi SS, To T, Jorns J, Yen T, Yu B, Ye DH.) Proc IEEE Int Symp Biomed Imaging. 2024 May;2024 PMID: 40313564 PMCID: PMC12045284 05/02/2025

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.